Founder, President and Chief Executive Officer
Prior to founding Orbus Therapeutics, Inc., Bob was a co-founder of Jazz Pharmaceuticals, Inc., in 2003. At Jazz, he served as President and was a member of the Board of Directors. From 2002 to 2003, he served as Executive Vice President, Pharmaceuticals at Exelixis, Inc. Previously, he held various positions with ALZA Corporation from 1992 to 2001, most recently as its Senior Vice President, Commercial Development. He received BS and MS degrees from Stanford University and an MBA from the Stanford Graduate School of Business.
Founder, Chief Operating Officer
Prior to founding Orbus Therapeutics, Jason was Chief Business Officer of Sorbent Therapeutics, Inc., a company focused on the development of oral polymers to treat chronic heart failure. Prior to Sorbent, he was Chief Business Officer at Brain Cells, Inc., a CNS focused drug discovery and development company. Before BrainCells, Jason was one of the initial employees at Jazz Pharmaceuticals, Inc. and was Vice President, Corporate Development. Before joining Jazz Pharmaceuticals, Jason was Director of Business Development at ALZA Corporation, a wholly owned subsidiary of Johnson & Johnson. He received a BA from the University of California, San Diego and a MBA from the University of Texas, McCombs Graduate School of Business.